EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disarming oxidized lipids: AAV-delivered antibody neutralization as an emerging strategy against ALS

Sergi Verdés, Assumpció Bosch

Molecular Therapy Advances · 2026-12 · 34 (4) · 201879

DOI: 10.1016/j.omta.2026.201879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-12. Verfasst von Sergi Verdés und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience (INc), and Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a progressive and devastating neurodegenerative disease affecting motor neurons (MNs) and the neuromuscular axis. Despite decades of research on its molecular trigger and pathological mechanisms, and the search for effective disease-modifying therapies, both questions remain largely unknown. A common feature of ALS, present in 97% of cases, is the mislocalization, aggregation, and functional disruption of TAR DNA-binding protein 43 (TDP-43),1 yet the upstream trigger of this proteinopathy is poorly understood.

Autor:innen und Institutionen

  • Institute of Neuroscience (INc), and Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Unitat Mixta UAB-VHIR, Vall D'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Zitieren

APA

Verdés, S., & Bosch, A. (2026). Disarming oxidized lipids: AAV-delivered antibody neutralization as an emerging strategy against ALS. Molecular Therapy Advances, 34(4), 201879. https://doi.org/10.1016/j.omta.2026.201879

Vancouver

Verdés S, Bosch A. Disarming oxidized lipids: AAV-delivered antibody neutralization as an emerging strategy against ALS. Molecular Therapy Advances. 2026;34(4):201879. doi:10.1016/j.omta.2026.201879

BibTeX
@article{Verds2026,
  author = {Verdés, Sergi and Bosch, Assumpció},
  title = {Disarming oxidized lipids: AAV-delivered antibody neutralization as an emerging strategy against ALS},
  journal = {Molecular Therapy Advances},
  year = {2026},
  volume = {34},
  number = {4},
  pages = {201879},
  doi = {10.1016/j.omta.2026.201879}
}
Kostenlos starten →